NCT06804083View on ClinicalTrials.gov

Bovine Colostrum Efficacy for the Treatment of Chronic Prostatitis Symptoms.

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

June 30, 2023

Conditions
Chronic Prostatitis (CP)Chronic Prostatitis With Chronic Pelvic Pain SyndromeChronic Prostatitis/ Pelvic Pain Syndrome
Interventions
DRUG

oral combination of colostrum and Serenoa repens extracts (PROSTYM®)

"The composition of PROSTYM® (per capsule) includes bovine colostrum (30 mg), Serenoa extracts (320 mg), glutathione (30 mg), N-acetyl cysteine (20 mg), Ribes nigrum extracts (50 mg), willow extracts (50 mg), zinc (5 mg), selenium (27.5 micrograms), and vitamin E (6 mg).~Drug administration (1 capsule per day) for 6 months."

Trial Locations (1)

10126

Molinette Hospital, Torino

All Listed Sponsors
collaborator

A.O.U. Città della Salute e della Scienza - Molinette Hospital

OTHER

lead

Clinica Urologica Molinette - Città della Saliute e della Scienza

OTHER

NCT06804083 - Bovine Colostrum Efficacy for the Treatment of Chronic Prostatitis Symptoms. | Biotech Hunter | Biotech Hunter